Literature DB >> 21295616

Acetylcholine: future research and perspectives.

E A Van der Zee1, B Platt, G Riedel.   

Abstract

Ever since the initial description of chemical transmission in the early part of the 20th century and the identification of acetylcholine (ACh) as the first such transmitter, interests grew to define the multiple facets of its functions. This multitude is only partially covered here, but even in the areas preselected for this special issue, research on the cholinergic system is still thriving. Notwithstanding an impressive amount of knowledge that has been accumulated, partly triggered by the cholinergic hypothesis of Alzheimer's disease (AD [1]), the different reviews in this issue not only summarise our current state of the art, they also highlight that this field has still large potential for future development. Taken from these reviews, we here pinpoint several topics fit for future attention.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295616     DOI: 10.1016/j.bbr.2011.01.050

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  10 in total

1.  Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors.

Authors:  Paola Costanzo; Luca Cariati; Doriana Desiderio; Roberta Sgammato; Anna Lamberti; Rosaria Arcone; Raffaele Salerno; Monica Nardi; Mariorosario Masullo; Manuela Oliverio
Journal:  ACS Med Chem Lett       Date:  2016-03-28       Impact factor: 4.345

Review 2.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

Review 3.  Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?

Authors:  Wilhelmina A M Vingerhoets; Oswald J N Bloemen; Geor Bakker; Therese A M J van Amelsvoort
Journal:  Front Psychiatry       Date:  2013-12-04       Impact factor: 4.157

4.  Amelioration of Scopolamine-Induced Learning and Memory Impairment by α-Pinene in C57BL/6 Mice.

Authors:  Gil-Yong Lee; Chan Lee; Gyu Hwan Park; Jung-Hee Jang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-01       Impact factor: 2.629

Review 5.  Vibration detection: its function and recent advances in medical applications.

Authors:  Tamás Oroszi; Marieke J G van Heuvelen; Csaba Nyakas; Eddy A van der Zee
Journal:  F1000Res       Date:  2020-06-17

Review 6.  Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain.

Authors:  Leon Stefanovski; Jil Mona Meier; Roopa Kalsank Pai; Paul Triebkorn; Tristram Lett; Leon Martin; Konstantin Bülau; Martin Hofmann-Apitius; Ana Solodkin; Anthony Randal McIntosh; Petra Ritter
Journal:  Front Neuroinform       Date:  2021-04-01       Impact factor: 4.081

Review 7.  Prescribed drugs containing nitrogen heterocycles: an overview.

Authors:  Majid M Heravi; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2020-12-15       Impact factor: 4.036

8.  Design and synthesis of new indole drug candidates to treat Alzheimer's disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy.

Authors:  Phoebe F Lamie; Maha M Abdel-Fattah; John N Philoppes
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

9.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

10.  A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.

Authors:  Xiao-Long Shi; Ning Yan; Ying-Jie Cui; Zhao-Peng Liu
Journal:  Cells       Date:  2020-03-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.